Sana Biotechnology Competitors and Similar CompaniesClear all
Amyris's competitors and similar companies include Nuclera and Editas Medicine.
 Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. |  Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ||
Founding Date | Founding Date 2003 | Founding Date 2013 | Founding Date 2013 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Sao Paulo, BR | Locations Cambridge, GB HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 1,0031% decrease | Employees 1192% decrease | Employees 20816% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) |
Net income | Net income ($543.4m) (FY, 2022) | Net income N/A | Net income ($160.1m) (FY, 2025) |
Funding | |||
Latest funding round | Latest funding round $ 34m (about 7 years ago) | Latest funding round $ 10m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 551.9m | Total funding raised $ 11.3m | Total funding raised $ 210m |
For sources of this data, please see the company profile
View Company Profiles
Nuclera
HQ
Cambridge, GB
Employees
119↓ 2% decrease
Nuclera is a company that specializes in DNA synthesis.
View companyEditas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company